A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors
Clinical trial NCT04931342 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04931342
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-07
- Primary completion
- 2028-02-28
- Enrollment
- 176
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.